Clinical Trial Update: Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on complement inhibition aimed at reducing inflammation after aneurysmal subarachnoid hemorrhage; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Snippet

Sponsor: Haaglanden Medical Centre | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Phase 2 | Status: RECRUITING